News

  • Mar 2014

    Coriell's Dr. Christman Discusses Personalized Medicine with Top Technology Publication

    In an exploratory article on of the explosive growth of personalized medicine and the important role technology plays in this paradigm shift, Coriell Institute's president and CEO, Dr. Michael Christman discusses the work being done by the Coriell Personalized Medicine Collaborative research study.

    read more

  • Mar 2014

    Coriell's Susan Delaney Honored by NJ General Assembly

    This March, Coriell's Director of Government Affairs and Policy, Susan Delaney, was honored alongside fellow New Jersey women leaders in the State Assembly chambers for leadership in the life sciences.

    read more

  • Mar 2014

    Coriell Science Fair Makes Splash with South Jersey Media

    Hundreds of students, teachers, family and friends turned up at the Camden County College campus in late March to support the region's stellar science education programs.

    read more

  • Feb 2014

    Coriell Institute Recognized as Key to Camden's Resurgence

    Coriell Institute was identified as a community leader contributing to the revival of industry in Camden in an article written by Philadelphia's NBC10 and NewsWorks, an extension of WHYY.

    read more

  • Feb 2014

    Coriell's Spin-off Poised to Make Big Impact

    Dr. Michael Christman, Coriell's President and CEO and a founding member of Coriell Life Sciences (CLS), and Scott Megill, President and CEO of CLS, spoke with Aaron Krol of Bio-IT World for an update on personalized medicine efforts at Coriell.

    read more

  • Dec 2013

    An Invaluable Research Resource

    Coriell Institute was recently awarded a milestone contract extension for its National Institute for Neurological Disorders and Stroke (NINDS) repository, which houses an extensive and diverse collection of biospecimens assembled to facilitate studies aimed at accelerating the discovery of disease-relevant biomarkers for neurological disorders and neurodegenerative diseases such as Parkinson's Disease and Huntington's Disease.

    read more

  • Dec 2013

    Coriell Scientists Publish Significant Paper

    Several Coriell scientific staff members contributed to a peer-reviewed publication on personalized medicine.

    read more

  • Nov 2013

    Tracking the Progress of Personalized Medicine

    As part of a conversation with PharmaPhorum, a prominent source for pharmaceutical industry news, trends, and policy, Dr. Michael Christman, Coriell Institute's President and CEO, details his promising outlook on the future of genome-informed healthcare.

    read more

  • Nov 2013

    Coriell Supports Local Cause

    Several Coriell Institute employees participated in the 2013 Cooper Norcross Run the Bridge event in early November.

    read more

  • Nov 2013

    Coriell's Dr. Kronenthal Receives Prestigious Award

    The Philadelphia Business Journal has recognized Dr. Courtney Kronenthal, Coriell's Director of Communications and Development, as a member of the 2013 Women of Distinction class.

    read more